Focused Medical Information LLC is categorized under Health Association in Denver, CO and active since 2000.
Focused Medical Information LLC was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Association business, which does work in the B2B market, and is classified as a Health Association, under code number 813920 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey Eyestone at the company’s single location by writing to 3131 East Alameda Avenue, Denver, Colorado CO 80209 or by phoning (303) 875-8743. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Focused Medical Information LLC |
| Contact Person: | Jeffrey Eyestone |
| Address: | 3131 East Alameda Avenue, Denver, Colorado 80209 |
| Phone Number: | (303) 875-8743 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Health Association |
| SIC Code: | 8621 |
| NAICS Code: | 813920 |
| Share This Business: |
Focused Medical Information LLC was started in 2000 to provide professional Health Association under the SIC code 8621 and NAICS code 813920. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jeffrey Eyestone for inquiries that concern Focused Medical Information LLC by calling the company number (303) 875-8743, as your correspondence is most welcome. Additionally, the physical location of the single location of Focused Medical Information LLC can be found at the coordinates 39.711148,-104.950147 as well as the street address 3131 East Alameda Avenue in Denver, Colorado 80209.
For its online presence, you may visit Focused Medical Information LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.